Join an Observational Pregnancy Study

MotherToBaby is currently enrolling pregnant women in a study examining the use of Dupixent® (dupilumab)‎ to treat moderate-to-severe eczema (atopic dermatitis) and asthma during pregnancy. The study is conducted through phone interviews—no changes to your normal routine or travel required. If you’ve taken Dupixent^® (dupilumab)‎ and are pregnant, you may qualify for this important study.‎ 

“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”

— Christina Chambers, PhD MPH, MotherToBaby Pregnancy Studies

Make an impact on maternal health by enrolling MotherToBaby is the most trusted information source for medication safety in pregnancy. Make an impact on maternal health by enrolling into our pregnancy study.